ALLMedicine™ Transfusion Reactions Center
Research & Reviews 409 results
https://doi.org/10.1111/trf.16926
Transfusion Grégoire Y, Delage G et. al.
May 14th, 2022 - The last economic evaluation of pathogen reduction technology (PRT) in Canada was conducted in 2007. We reassessed the cost-effectiveness of PRT in the province of Québec (which has its own blood supplier) and included an evaluation of the potenti...
https://doi.org/10.1080/17474086.2022.2077721
Expert Review of Hematology; Finelli C, Parisi S et. al.
May 14th, 2022 - Anemia is often present in mostly elderly patients with myelodysplastic syndromes (MDS), and is associated with a poorer outcome. Although red blood cell (RBC) transfusions are the most immediate treatment, waiting for the response to disease-spec...
https://doi.org/10.1111/tme.12871
Transfusion Medicine (Oxford, England); Krajibthong S, Sahntipurna V et. al.
May 10th, 2022 - Recent studies revealed the glucose-6-phosphate dehydrogenase (G-6-PD) deficiency prevalence of 7.7-10% among Thai blood donors. Transfusion of red blood cells (RBCs) from these subjects potentially causes haemolysis in recipients. RBC units from ...
https://clinicaltrials.gov/ct2/show/NCT05240391
May 10th, 2022 - Paracentesis-induced circulatory disturbance (PICD) is a very common cause of mortality and morbidity in patients undergoing large-volume paracentesis. Albumin is commonly used in decompensated cirrhosis during large-volume paracentesis. However, ...
https://doi.org/10.1016/j.tmrv.2022.04.002
Transfusion Medicine Reviews; Tacquard C, Andreu G et. al.
May 3rd, 2022 - Few data are currently available on hypersensitivity transfusion reactions (HTRs) after exposure to fresh frozen plasma (FFP). Between 2000 and 2018, three different FFP production strategies have been used in France, leading to the concomitant us...
Guidelines 2 results
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6988392
Blood Advances; Chou ST, Alsawas M et. al.
Jan 28th, 2020 - Red cell transfusions remain a mainstay of therapy for patients with sickle cell disease (SCD), but pose significant clinical challenges. Guidance for specific indications and administration of transfusion, as well as screening, prevention, and ma...
https://doi.org/10.1111/trf.14611
Transfusion Compernolle V, Chou ST et. al.
Apr 27th, 2018 - Red blood cell (RBC) transfusions remain essential in the treatment of patients with sickle cell disease (SCD) and β-thalassemia. Alloimmunization, a well-documented complication of transfusion, increases the risk of delayed hemolytic transfusion ...
Drugs 167 results see all →
Clinicaltrials.gov 15 results
https://clinicaltrials.gov/ct2/show/NCT05240391
May 10th, 2022 - Paracentesis-induced circulatory disturbance (PICD) is a very common cause of mortality and morbidity in patients undergoing large-volume paracentesis. Albumin is commonly used in decompensated cirrhosis during large-volume paracentesis. However, ...
https://clinicaltrials.gov/ct2/show/NCT02314988
Mar 8th, 2022 - Reducing perioperative blood loss is critically important in the treatment of multiply injured combat casualties, and major blood loss during complex spine trauma surgery is a significant concern. Similar to previous studies in dental, cardiac, an...
https://clinicaltrials.gov/ct2/show/NCT02564796
Dec 2nd, 2021 - Congenital heart disease occurs in about 1% of all live births. Cyanotic cardiac lesions in particular are at risk for significant mortality and morbidity because of their reduced ability to provide adequate oxygenation to the body and the brain. ...
https://clinicaltrials.gov/ct2/show/NCT04000165
Sep 10th, 2021 - Sickle cell disease (SCD) is a multisystem disorder associated with episodes of acute clinical events and progressive organ damage. Episodic pain, triggered by micro-vasoocclusion induced by sickled red blood cells, is the most common acute compli...
https://clinicaltrials.gov/ct2/show/NCT03182491
Jun 16th, 2021 - The purpose of this study is to explore different mechanisms for anaphylaxis and find novel biomarkers for this hypersensitivity syndrome. The study participants are patients with anaphylaxis, patients with mild allergic reactions, and patients wi...
News 24 results
https://www.medscape.com/viewarticle/971657
Apr 6th, 2022 - MANCHESTER — Over a fifth of reported blood transfusion reactions are in patients with sickle cell disease, over half of which involve the potentially life-threatening complication hyperhaemolysis, suggests a UK analysis. "Haemolytic transfusion r...
https://www.onclive.com/view/induction-and-post-induction-therapy-for-adult-all
Apr 2nd, 2021 - Transcript:Bijal D. Shah, MD: Risk stratification in acute lymphoblastic leukemia (ALL) is absolutely the next most important thing we can do to improve outcomes. Now, risk stratification involves, I think, fundamentally two components. The first ...
https://www.onclive.com/view/management-of-cancer-related-anemia-in-2011
Dec 5th, 2020 - Eric H. Kraut, MD Erythropoietin-stimulating agents (ESAs), once considered miracle drugs that enjoyed widespread use for cancer-related anemia, fell into disfavor in 2007, when evidence demonstrated that ESAs decreased survival and time to dise...
https://www.staging.medscape.com/viewarticle/927716
Mar 28th, 2020 - Editor's note: Find the latest COVID-19 news and guidance in Medscape's Coronavirus Resource Center. As the proportion of patients infected with COVID-19 continues to rise in the United States, the Food and Drug Administration is facilitating acc...
https://www.medscape.com/viewarticle/927716
Mar 28th, 2020 - Editor's note: Find the latest COVID-19 news and guidance in Medscape's Coronavirus Resource Center. As the proportion of patients infected with COVID-19 continues to rise in the United States, the Food and Drug Administration is facilitating acc...
